HomeProductDanh muc sản phẩm Danh muc sản phẩm

XALATAN

XALATAN

Code :

Price: Contact

Manufacturer                          
  •       Pfizer
Present/Packing          Xalatan 50 mcg/1 mL x 2.5 mL x 1's
Price                    

Features    
     

Delivery




Share this product to others

Shopping
guide
Add to cart

XALATAN

Manufacturer:

          Pfizer 

Contents:

          Latanoprost

Indications:

          Reduction of elevated IOP in open-angle glaucoma, ocular HTN, paed patients w/ elevated IOP & glaucoma. Adjunct medical therapy for reduction of elevated IOP in primary chronic angle-closure glaucoma.

Contraindications:

          Hypersensitivity to any of the ingredients

Special Precautions:

          Possibility of permanent change in eye colour. Monitor patients for increase in iris pigmentation. Heterochromia (unilateral treatment). Eyelid skin darkening, eyelash changes (reversible). Aphakic patients, pseudophakic patients w/ torn posterior lens capsule or anterior chamber lenses, risk factors for cystoid macular oedema. Chronic angle-closure glaucoma, open-angle glaucoma of pseudophakic patients, pigmentary glaucoma, inflammatory & neovascular glaucoma, inflammatory ocular conditions; acute attacks of closed-angle glaucoma. Peri-op period of cataract surgery. Predisposing risk factors for iritis/uveitis; severe or brittle asthma; periorbital skin discolouration in Japanese patients; history of herpetic keratitis (including recurrent cases associated w/ prostaglandin analogues); active herpes simplex keratitis. Remove contact lenses before instillation (may be reinserted after 15 min). May impair ability to drive or operate machinery. Pregnancy & lactation. Childn.

Dosage:

          Elderly, adult & childn Instill 1 drop in the affected eye(s) once daily in the evening.

Class:

          Antiglaucoma Preparations

Presentation/Packing:

          Xalatan 50 mcg/1 mL x 2.5 mL x 1's

Details:

          MyPhuocPharmacy – (08) 62581003

Latanoprost

Elderly, adult & childn Instill 1 drop in the affected eye(s) once daily in the evening.

Updating

Possibility of permanent change in eye colour. Monitor patients for increase in iris pigmentation. Heterochromia (unilateral treatment). Eyelid skin darkening, eyelash changes (reversible). Aphakic patients, pseudophakic patients w/ torn posterior lens capsule or anterior chamber lenses, risk factors for cystoid macular oedema. Chronic angle-closure glaucoma, open-angle glaucoma of pseudophakic patients, pigmentary glaucoma, inflammatory & neovascular glaucoma, inflammatory ocular conditions; acute attacks of closed-angle glaucoma. Peri-op period of cataract surgery. Predisposing risk factors for iritis/uveitis; severe or brittle asthma; periorbital skin discolouration in Japanese patients; history of herpetic keratitis (including recurrent cases associated w/ prostaglandin analogues); active herpes simplex keratitis. Remove contact lenses before instillation (may be reinserted after 15 min). May impair ability to drive or operate machinery. Pregnancy & lactation. Childn.

Rating

(based on 0 rating)

We want to know your comment!


Write a review


     
  Rating
  Email *
  Fullname *
  Title *
  Content *
  Confirm code *